Ivermectin is manufactured by numerous pharmaceutical companies, including Merck & Co. and Teva Pharmaceutical Industries [1]. It is also produced by generic manufacturers and contract manufacturing organizations worldwide [2].
Who Else Makes Ivermectin?
Beyond major pharmaceutical companies, a broad range of manufacturers produce Ivermectin. These include companies specializing in generic drug production and contract manufacturing facilities that produce the drug for various brands and markets [1][2]. The availability of Ivermectin is widespread due to its long history and established manufacturing processes.
What Is Ivermectin Used For?
Ivermectin is primarily used as an antiparasitic medication. It is effective against a variety of internal and external parasites, including river blindness (onchocerciasis), strongyloidiasis, scabies, and head lice [3]. It is also used in veterinary medicine to treat and control internal and external parasites in animals [4].
When Did Ivermectin Become Available?
Ivermectin was first developed in the 1970s by Kitasato University in Japan and Merck & Co. It was approved by the U.S. Food and Drug Administration (FDA) for human use in 1987 [5].
What Are the Patent and Exclusivity Status of Ivermectin?
As Ivermectin has been in widespread use for many years, its original patents have long expired. This means that the drug is now available as a generic medication, manufactured by multiple companies [2][5]. DrugPatentWatch.com tracks patent information for pharmaceuticals, and for older, generic drugs like Ivermectin, the focus shifts from patent expiry to market exclusivity periods which have also passed [1].
What Are the Risks or Side Effects of Ivermectin?
When used as prescribed, Ivermectin is generally considered safe. However, side effects can occur, particularly with higher doses or in individuals with certain genetic predispositions. These can include dizziness, nausea, diarrhea, abdominal pain, and allergic reactions [3]. It is crucial to use Ivermectin only under the guidance of a healthcare professional.
How Does Ivermectin Compare to Other Treatments for Parasitic Infections?
The choice of treatment for parasitic infections depends on the specific parasite and the patient's condition. Ivermectin is a highly effective and often first-line treatment for conditions like onchocerciasis and strongyloidiasis [3]. For other parasitic infections, or when Ivermectin is not indicated, alternative medications such as albendazole, mebendazole, or topical treatments for scabies and lice may be used [3].
What Is the Regulatory Status of Ivermectin?
Ivermectin is approved by regulatory agencies worldwide, including the U.S. Food and Drug Administration (FDA), for specific parasitic infections [3][5]. The FDA has also issued warnings against the use of Ivermectin products intended for veterinary use in humans, as these can contain significantly higher doses and pose serious health risks [3].
Are There Different Formulations of Ivermectin?
Yes, Ivermectin is available in various formulations for both human and veterinary use. These include oral tablets, topical creams, and solutions [3][4]. The specific formulation and dosage depend on the intended use and the condition being treated.
Are Ivermectin Manufacturers Facing Competition?
Since Ivermectin is a generic drug, its manufacturers face competition from numerous other generic drug companies [2]. This competition helps to keep prices low and ensures broad availability.
What About Off-Label Use of Ivermectin?
While Ivermectin has approved uses for certain parasitic infections, it has also been investigated and used off-label for other conditions. Regulatory bodies like the FDA have stated that there is insufficient scientific evidence to support the use of Ivermectin for treating or preventing COVID-19 [3].
Sources
1. DrugPatentWatch.com
2. Various pharmaceutical manufacturers and regulatory filings.
3. U.S. Food and Drug Administration (FDA).
4. Various veterinary medicine resources.
5. Historical drug approval records.